Precision without invasion:
using Liquid Biopsy to improve patient
wellness and care decisions

Liquid Biopsy. Limitless Possibilities.

Welcome to Liquid Biopsy Research Alliance

Detect Early. Treat Smarter. Live Longer.

The Liquid Biopsy Research Alliance (LIBRA) is a not-for-profit initiative dedicated to advancing cancer diagnostics and precision oncology through the promotion and integration of liquid biopsy technologies in India & Globe. Established in 2025, LIBRA aims to bridge the gap between cutting-edge molecular technologies and everyday oncology practice by promoting the adoption and integration of liquid biopsy—a non-invasive, real-time diagnostic approach.

At the heart of our mission is the belief that every individual deserves access to timely, accurate, and personalized cancer diagnostics, regardless of their socio-economic status or geographic location. Together, we strive to revolutionize cancer diagnostics—one drop at a time.

Know More
Give the Gift of Early Diagnosis

What We Do?

At LIBRA, we are dedicated to transforming cancer care through the power of liquid biopsy and precision diagnostics. Our work focuses on making non-invasive, real-time cancer detection and monitoring accessible, affordable, and impactful for everyone—regardless of geography or economic background.

New Blood Test Detects 16 Cancers | Early Diagnosis & Screenings

LIBRA Foundation

Your Donation Can Help Us Detect Cancer Earlier and Save Lives Across the Globe.

Donate Now!

Academic Programs

Liquid Biopsy Webinar

Panel Discussion

Screening Campaign

Liquid Biopsy & Interaction with Experts

Liquid Biopsy NGS

Publications

Next-generation U-Net Encoder: Decoder for accurate, automated CTC detection from images of peripheral blood nucleated cells stained with EPCAM and DAPI.

28 May, 2025
Read Article

Circulating tumor DNA profiling for non-invasive genomic analysis in Indian lung cancer patients: A real-world experience.

10 June, 2025
Read Article

Liquid Biopsy for Detection of Pancreaticobiliary Cancers by Functional Enrichment and Immunofluorescent Profiling of Circulating Tumor Cells and Their Clusters.

2 April, 2024
Read Article
Read More Articles